Ciwujianoside C3 is primarily studied for its potential anti-inflammatory and immunomodulatory effects. It has shown activity in regulating cytokine production, which may help in managing chronic inflammatory conditions. Research suggests it can influence signaling pathways such as NF-κB, making it a candidate for development in treating autoimmune diseases and inflammation-related disorders. Additionally, it exhibits antioxidant properties, contributing to cellular protection against oxidative stress. These characteristics make it of interest in pharmaceutical and nutraceutical applications, particularly in formulations aimed at immune support and inflammation control.